Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease

There is a clinical need for direct-acting antivirals targeting SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic, to complement current therapeutic strategies. The main protease (M(pro)) is an attractive target for antiviral therapy. However, the vast majority of protease inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Deshmukh, Maya G., Ippolito, Joseph A., Zhang, Chun-Hui, Stone, Elizabeth A., Reilly, Raquel A., Miller, Scott J., Jorgensen, William L., Anderson, Karen S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218531/
https://www.ncbi.nlm.nih.gov/pubmed/34161756
http://dx.doi.org/10.1016/j.str.2021.06.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218531/
https://www.ncbi.nlm.nih.gov/pubmed/34161756
http://dx.doi.org/10.1016/j.str.2021.06.002

Ejemplares similares